CIA Sues Author in Prepublication Review Dispute
The Central Intelligence Agency has filed a lawsuit against one of its own former employees after he published a book on intelligence without first getting the CIA’s prior approval, the Washington Times reported today.
A book called “The Human Factor: Inside the CIA’s Dysfunctional Intelligence Culture” was written by a former CIA clandestine services officer under the pen name Ishmael Jones. It was published earlier this year, the government says, “in defiance of the CIA’s Publications Review Board’s disapproval and instructions not to publish.” See “CIA sues ex-agent for book’s breach of ‘secrecy'” by Bill Gertz, Washington Times, October 19, 2010.
The CIA’s complaint (pdf) against Jones, filed in July, says that he violated the terms of the non-disclosure agreement that he signed as a condition of his employment and that, as a result, he is in breach of contract.
As a first order of business, the CIA sought (pdf) and gained the Court’s approval (pdf) to proceed against Jones using his pseudonym since, the Agency argued, disclosing his real name could compromise national security.
“For CIA officers to effectively and securely collect foreign intelligence and conduct clandestine foreign intelligence activities around the world, they cannot openly admit that they work for the CIA,” the government brief explained.
But “if defendant’s true name and affiliation with the CIA were officially acknowledged, foreign governments, enterprising journalists, and amateur spy-hunters would be able to discover and publicly disclose the cover methods defendant used to conceal his true status as a CIA officer,” the brief said.
The class of persons who constitute “amateur spy-hunters” was not further identified.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line